Cargando…
Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection continues to be a serious global public health threat. The 3C-like protease (3CLpro) is a virus protease encoded by SARS-CoV-2, which is essential for virus replication. We have previously reported a series of small-molecule 3CLp...
Autores principales: | Dampalla, Chamandi S., Zheng, Jian, Perera, Krishani Dinali, Wong, Lok-Yin Roy, Meyerholz, David K., Nguyen, Harry Nhat, Kashipathy, Maithri M., Battaile, Kevin P., Lovell, Scott, Kim, Yunjeong, Perlman, Stanley, Groutas, William C., Chang, Kyeong-Ok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307543/ https://www.ncbi.nlm.nih.gov/pubmed/34210738 http://dx.doi.org/10.1073/pnas.2101555118 |
Ejemplares similares
-
3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV–infected mice
por: Rathnayake, Athri D., et al.
Publicado: (2020) -
Potent Protease Inhibitors of Highly Pathogenic Lagoviruses: Rabbit Hemorrhagic Disease Virus and European Brown Hare Syndrome Virus
por: Perera, Krishani Dinali, et al.
Publicado: (2022) -
Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor
por: Perera, Krishani Dinali, et al.
Publicado: (2019) -
Protease inhibitors broadly effective against feline, ferret and mink coronaviruses
por: Perera, Krishani Dinali, et al.
Publicado: (2018) -
Structure-guided design of direct-acting antivirals that exploit the gem-dimethyl effect and potently inhibit 3CL proteases of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) and middle east respiratory syndrome coronavirus (MERS-CoV)
por: Dampalla, Chamandi S., et al.
Publicado: (2023)